LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/CMS Gives Reporting Relief to Providers
Legal & Regulatory and Reimbursement

CMS Gives Reporting Relief to Providers

March 25, 2020 2 min read Premium comments

Advertisement

CMS Gives Reporting Relief to Providers
Source: RRY Publications LLC ©
Secondary#cms#covid19#qualitymeasurereporting

Responding to requests from providers during the COVID-19 pandemic, Centers for Medicare and Medicaid Services (CMS) announced on March 22, 2020, that it was providing reporting relief for clinicians, providers, hospitals and facilities participating in quality reporting programs during the fourth quarter of 2019.

Reducing Data Collection and Reporting Burden

The agency stated it knows that quality measure data collection and reporting for services during this period may not accurately reflect the true level of performance on measures such as cost, readmissions and patient experience. It will hold organizations harmless for not submitting data during this period.

The agency also said it will not use any quality data on services from January 1 through June 30 of this year in the agency’s calculations for quality reporting and value-based purchasing programs.

“This is being done to reduce the data collection and reporting burden on providers responding to the Covid-19 pandemic,” stated the agency press release.

Extended Deadlines

Specifically, CMS extended the deadline for the Merit-based Incentive Payment System (MIPS) and accountable care organizations (ACOs) in the Medicare Shared Savings Program (MSSP) to submit 2019 data. The original deadline was March 31, but they now have until April 30 to submit quality data from 2019.

However, CMS said it is still evaluating its options for “providing relief around participation and data submission for 2020” for the MIPS and MSSP programs.

Advertisement

The agency said that MIPS-eligible physicians who haven’t submitted any data for the program by April 30 will still qualify for relief and get a “neutral payment adjustment for the 2021 MIPS payment year.”

Hospitals won’t need to submit data from January 1 until June 30, 2020 for programs targeting kidney disease and hospital-acquired conditions. Post-acute care programs such as the hospice and home health quality reporting programs and the long-term hospital quality program are also included in the relief. However, there is no mention of the application deadline for the direct contracting program for ACOs.

“CMS’ decision to offer relief from the reporting demands in the Quality Payment Program will be felt immediately,” said Patrice Harris, M.D., president of the American Medical Association, in a statement. “Doctors don’t have much time to breathe a sigh of relief, but if they did, they would take a moment to thank CMS for this wise decision.”

Additional Options Considered

The agency said it will continue monitoring the developing COVID-19 situation and “assess options to bring additional relief to clinicians, facilities, and their staff so they can focus on caring for patients.”

To read the official CMA announcement, click here.

To keep up with government action in response to COVID-19, please visit www.coronavirus.gov. For a complete and updated list of CMS actions, and other information specific to CMS, please visit the Current Emergencies Website.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy